Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biochemistry and function of the DISC.
Walczak H, Sprick MR. Walczak H, et al. Trends Biochem Sci. 2001 Jul;26(7):452-3. doi: 10.1016/s0968-0004(01)01895-3. Trends Biochem Sci. 2001. PMID: 11440858 No abstract available.
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH, Walczak H. Sprick MR, et al. Immunity. 2000 Jun;12(6):599-609. doi: 10.1016/s1074-7613(00)80211-3. Immunity. 2000. PMID: 10894160
Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.
Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H. Sprick MR, et al. EMBO J. 2002 Sep 2;21(17):4520-30. doi: 10.1093/emboj/cdf441. EMBO J. 2002. PMID: 12198154 Free PMC article.
TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus.
Washburn B, Weigand MA, Grosse-Wilde A, Janke M, Stahl H, Rieser E, Sprick MR, Schirrmacher V, Walczak H. Washburn B, et al. J Immunol. 2003 Feb 15;170(4):1814-21. doi: 10.4049/jimmunol.170.4.1814. J Immunol. 2003. PMID: 12574346
The interplay between the Bcl-2 family and death receptor-mediated apoptosis.
Sprick MR, Walczak H. Sprick MR, et al. Biochim Biophys Acta. 2004 Mar 1;1644(2-3):125-32. doi: 10.1016/j.bbamcr.2003.11.002. Biochim Biophys Acta. 2004. PMID: 14996497 Review.
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC, Krueger A, Weigand MA, Grosse-Wilde A, Stremmel W, Krammer PH, Walczak H. Ganten TM, et al. Cell Death Differ. 2004 Jul;11 Suppl 1:S86-96. doi: 10.1038/sj.cdd.4401437. Cell Death Differ. 2004. PMID: 15105837
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
Wenger T, Mattern J, Penzel R, Gassler N, Haas TL, Sprick MR, Walczak H, Krammer PH, Debatin KM, Herr I. Wenger T, et al. Cell Death Differ. 2006 Oct;13(10):1740-51. doi: 10.1038/sj.cdd.4401867. Epub 2006 Feb 10. Cell Death Differ. 2006. PMID: 16470224
Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effects.
Wenger T, Mattern J, Haas TL, Sprick MR, Walczak H, Debatin KM, B├╝chler MW, Herr I. Wenger T, et al. Cancer Gene Ther. 2007 Mar;14(3):316-26. doi: 10.1038/sj.cgt.7701016. Epub 2006 Dec 22. Cancer Gene Ther. 2007. PMID: 17186015
Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Koschny R, Holland H, Sykora J, Haas TL, Sprick MR, Ganten TM, Krupp W, Bauer M, Ahnert P, Meixensberger J, Walczak H. Koschny R, et al. Clin Cancer Res. 2007 Jun 1;13(11):3403-12. doi: 10.1158/1078-0432.CCR-07-0251. Clin Cancer Res. 2007. PMID: 17545549
49 results
Jump to page
Feedback